Tsabedze, Nqoba http://orcid.org/0000-0002-7210-1447
Ramsay, Michele http://orcid.org/0000-0002-4156-4801
Krause, Amanda http://orcid.org/0000-0002-7157-0807
Wells, Quinn http://orcid.org/0000-0003-3899-0313
Mpanya, Dineo http://orcid.org/0000-0003-3769-4686
Manga, Pravin http://orcid.org/0000-0002-2709-2158
Funding for this research was provided by:
South African Heart Association
South African Medical Association
Discovery Foundation
Carnegie Corporation of New York (B8749.RO1)
University of the Witwatersrand
Article History
Accepted: 15 February 2023
First Online: 14 March 2023
Declarations
:
: Ethical approval waived since the article is a narrative review that does not contain identifiable patient data. However, the data depicted in Fig. InternalRef removed was collected as part of “The Genetics of idiopathic dilated cardiomyopathy in Johannesburg Study”. The study complied with the Declaration of Helsinki, and informed consent was obtained from the study participants. Approval to conduct the study was granted by the University of the Witwatersrand Human Research Ethics Committee (Ethics Clearance certificate number: M150467).
: NT is a cardiologist and has received consultation fees from Acino Health Care Group, AstraZeneca, Boston Scientific, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Sanofi, Phillips, Servier, Takeda, and Merck. He has also received educational and travel grants from Medtronic, Biotronik, Boston Scientific, and Vertice Health Care Group. None of the other authors has any relevant financial or professional disclosures.